BRD4 and breast carcinoma: This is supported by a recent report which indicates that even when the bromodomain of BRD4 is inhibited, its interaction with transcriptional co-activators in breast cancer is unimpeded due to the presence of a longer isoform capable of maintaining protein-protein interactions [45].